Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shan Xiong

Showing results (141-150 of 161) with videos related to

Pageof 17
Sort By:
Annals of Palliative Medicine|April 9, 2021
Early extubation in operating room after single-lung transplantation: a single institutional experienceQing Ai, Hongsheng Deng, Danxia Huang, et al.
Blood|September 28, 2021
PEG10 amplification at 7q21.3 potentiates large-cell transformation in cutaneous T-cell lymphomaFengjie Liu, Yumei Gao, Bufang Xu, et al.
Cancer Medicine|October 13, 2020
Cancer risk in heart or lung transplant recipients: A comprehensive analysis of 21 prospective cohortsFan Ge, Caichen Li, Xin Xu, et al.
European Radiology|March 29, 2022
Predicting EGFR mutation status in lung adenocarcinoma presenting as ground-glass opacity: utilizing radiomics model in clinical translationBo Cheng, Hongsheng Deng, Yi Zhao, et al.
Oncoimmunology|December 10, 2020
Cancer Risks in Solid Organ Transplant Recipients: Results from a Comprehensive Analysis of 72 Cohort StudiesZhenyu Huo, Caichen Li, Xin Xu, et al.
Frontiers in Pharmacology|February 21, 2020
Hypertensive Rats Treated Chronically With N<sup>ω</sup>-Nitro-L-Arginine Methyl Ester (L-NAME) Induced Disorder of Hepatic Fatty Acid Metabolism and Intestinal PathophysiologyBo Li, Xinglishang He, Shan-Shan Lei, et al.
Translational Lung Cancer Research|January 10, 2022
Comparison of first-generation EGFR-TKIs (gefitinib, erlotinib, and icotinib) as adjuvant therapy in resected NSCLC patients with sensitive EGFR mutationsQihua He, Jun Liu, Xiuyu Cai, et al.
Translational Lung Cancer Research|May 9, 2022
Macrophages-based immune-related risk score model for relapse prediction in stage I-III non-small cell lung cancer assessed by multiplex immunofluorescenceXiang-Rong Wu, Hao-Xin Peng, Miao He, et al.
Therapeutic Advances in Medical Oncology|January 6, 2021
PD-L1 expression with respect to driver mutations in non-small cell lung cancer in an Asian population: a large study of 1370 cases in ChinaCaichen Li, Jun Liu, Zhanhong Xie, et al.
Chinese Medical Journal Pulmonary and Critical Care Medicine|August 22, 2024
Asian, regional, and national burdens of respiratory tract cancers and associated risk factors from 1990 to 2019: A systematic analysis for the global burden of disease study 2019Ran Zhong, Xiuyu Cai, Jianfu Li, et al.
Pageof 17

Showing results (141-150 of 161) with videos related to

Sort By:
Pageof 17
Annals of Palliative Medicine|April 9, 2021
Early extubation in operating room after single-lung transplantation: a single institutional experienceQing Ai, Hongsheng Deng, Danxia Huang, et al.
Blood|September 28, 2021
PEG10 amplification at 7q21.3 potentiates large-cell transformation in cutaneous T-cell lymphomaFengjie Liu, Yumei Gao, Bufang Xu, et al.
Cancer Medicine|October 13, 2020
Cancer risk in heart or lung transplant recipients: A comprehensive analysis of 21 prospective cohortsFan Ge, Caichen Li, Xin Xu, et al.
European Radiology|March 29, 2022
Predicting EGFR mutation status in lung adenocarcinoma presenting as ground-glass opacity: utilizing radiomics model in clinical translationBo Cheng, Hongsheng Deng, Yi Zhao, et al.
Oncoimmunology|December 10, 2020
Cancer Risks in Solid Organ Transplant Recipients: Results from a Comprehensive Analysis of 72 Cohort StudiesZhenyu Huo, Caichen Li, Xin Xu, et al.
Frontiers in Pharmacology|February 21, 2020
Hypertensive Rats Treated Chronically With N<sup>ω</sup>-Nitro-L-Arginine Methyl Ester (L-NAME) Induced Disorder of Hepatic Fatty Acid Metabolism and Intestinal PathophysiologyBo Li, Xinglishang He, Shan-Shan Lei, et al.
Translational Lung Cancer Research|January 10, 2022
Comparison of first-generation EGFR-TKIs (gefitinib, erlotinib, and icotinib) as adjuvant therapy in resected NSCLC patients with sensitive EGFR mutationsQihua He, Jun Liu, Xiuyu Cai, et al.
Translational Lung Cancer Research|May 9, 2022
Macrophages-based immune-related risk score model for relapse prediction in stage I-III non-small cell lung cancer assessed by multiplex immunofluorescenceXiang-Rong Wu, Hao-Xin Peng, Miao He, et al.
Therapeutic Advances in Medical Oncology|January 6, 2021
PD-L1 expression with respect to driver mutations in non-small cell lung cancer in an Asian population: a large study of 1370 cases in ChinaCaichen Li, Jun Liu, Zhanhong Xie, et al.
Chinese Medical Journal Pulmonary and Critical Care Medicine|August 22, 2024
Asian, regional, and national burdens of respiratory tract cancers and associated risk factors from 1990 to 2019: A systematic analysis for the global burden of disease study 2019Ran Zhong, Xiuyu Cai, Jianfu Li, et al.
Pageof 17